Minister Jorritsma opens DSM's new antibiotics plant in Delft
Market Leader
"Using our advanced technology basis, DSM is strengthening its position as the global leader in bulk antibiotics with this investment," says Nico Gerardu, director of DSM's Anti-Infectives Business Group. DSM Anti-Infectives has recently undergone a major reorganization process, necessitated by the substantial drop in the price of penicillin in the past few years. "The successful start-up of our 7-ADCA plant marks the recovery of DSM Anti-Infectives," explains Mr Gerardu. "We have experienced some hard times, but we're now definitely on the up. This investment, among other things, ensures that DSM Anti-Infectives can look confidently into the future again."
7-ADCA
7-ADCA (7-amino-deacetoxy-cephalosporinic acid) is an essential raw material for the production of cephalosporins, an important group of antibiotics. Antibiotics are medicines that are used to combat bacterial infections. They represent a major share of the overall pharmaceuticals market. Antibiotics derived from penicillin are by far the most important products in this market. There are two main groups of penicillin-derived antibiotics: semi-synthetic penicillins (among which are ampicillin and amoxycillin) and semi-synthetic cephalosporins (such as cephalexin and cephadroxyl).
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
ERBAdry by CARLO ERBA Reagents
Anhydrous solvents from CARLO ERBA Reagents in a clever redesign
ERBAdry series impresses with the latest generation of septa and sealing caps
Thermo Scientific™ Dionex™ ASE™ 150 or 350 Accelerated Solvent Extractor systems by Thermo Fisher Scientific
Accelerated Solvent Extraction (ASE) – Maximize results and reduce errors in food analysis!
More extractions in less time using less solvent
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.